22.1 Companies must have a scientific service to compile and collate all information, whether received from medical representatives or from any other source, about the medicines which they market.
22.2 Companies must also have a scientific service to deal
with the approval and supervision of non- interventional studies. This scientific service must include a registered medical practitioner or a pharmacist registered in the UK, who will be responsible for the oversight of noninterventional studies (including the review of any responsibilities relating to such studies, particularly those given to medical representatives). That person must state in writing that he or she has examined the protocol relating to the non- interventional study and that in his or her belief it is in accordance with the requirements of the Code.
Clauses 22.1 and 22.2 Scientific Services
Companies are free to decide whether there is one scientific service in charge of both responsibilities or separate services with clearly delineated duties.
Clause 14 does not apply to the examination of noninterventional studies.